Millipore Corporation Supports Presidential Order On Stem Cell Research

Millipore Corporation (NYSE:MIL), a provider of technologies, tools and services for the global life science industry, is supporting an executive order signed by President Barack Obama at the White House today, which rescinds limits on federal funding of stem cell research. Millipore is a leading provider of stem cell products to the biomedical research community.

More: continued here

Filed under: Stem Cell Research on March 13th, 2009